Northern Trust Corp Myriad Genetics Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Northern Trust Corp holds 967,209 shares of MYGN stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

967,209

Previous 933,921 3.56%

Holding current value

$15 Million

Previous $22.8 Million 15.89%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$23.97 - $28.6 $797,913 - $952,036	33,288 Added 3.56%	967,209 $26.5 Million
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $403,381 - $571,419	-22,435 Reduced 2.35%	933,921 $22.8 Million
Q1 2024 May 14, 2024	BUY	$17.59 - $23.59 $250,112 - $335,426	14,219 Added 1.51%	956,356 $20.4 Million
Q4 2023 Feb 13, 2024	SELL	$13.91 - $21.32 $1.11 Million - $1.71 Million	-80,002 Reduced 7.83%	942,137 $18 Million
Q3 2023 Nov 13, 2023	BUY	$15.99 - $23.22 $35,785 - $51,966	2,238 Added 0.22%	1,022,139 $16.4 Million
Q2 2023 Aug 11, 2023	BUY	$17.56 - $23.76 $398,717 - $539,494	22,706 Added 2.28%	1,019,901 $23.6 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $185,576 - $288,823	-12,161 Reduced 1.2%	997,195 $23.2 Million
Q4 2022 Feb 13, 2023	SELL	$14.51 - $20.99 $2.82 Million - $4.08 Million	-194,425 Reduced 16.15%	1,009,356 $14.6 Million
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $591,169 - $905,096	-32,464 Reduced 2.63%	1,203,781 $23 Million
Q2 2022 Aug 12, 2022	SELL	$16.45 - $25.88 $122,026 - $191,977	-7,418 Reduced 0.6%	1,236,245 $22.5 Million
Q1 2022 May 13, 2022	SELL	$22.67 - $28.01 $933,074 - $1.15 Million	-41,159 Reduced 3.2%	1,243,663 $31.3 Million
Q4 2021 Feb 08, 2022	SELL	$24.13 - $32.63 $24,636 - $33,315	-1,021 Reduced 0.08%	1,284,822 $35.5 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $976,482 - $1.19 Million	-32,582 Reduced 2.47%	1,285,843 $41.5 Million
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $1.39 Million - $1.79 Million	54,934 Added 4.35%	1,318,425 $40.3 Million
Q1 2021 May 12, 2021	SELL	$19.92 - $31.6 $8.94 Million - $14.2 Million	-448,625 Reduced 26.2%	1,263,491 $38.5 Million
Q4 2020 Feb 11, 2021	SELL	$12.16 - $19.77 $1.81 Million - $2.94 Million	-148,739 Reduced 7.99%	1,712,116 $33.9 Million
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $703,451 - $922,302	-62,529 Reduced 3.25%	1,860,855 $24.3 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $356,490 - $549,908	33,348 Added 1.76%	1,923,384 $21.8 Million
Q1 2020 May 14, 2020	BUY	$9.78 - $29.53 $87,081 - $262,935	8,904 Added 0.47%	1,890,036 $27 Million
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $328,245 - $550,473	-15,683 Reduced 0.83%	1,881,132 $51.2 Million
Q3 2019 Nov 13, 2019	BUY	$22.08 - $47.08 $2.24 Million - $4.77 Million	101,347 Added 5.64%	1,896,815 $54.3 Million
Q2 2019 Aug 13, 2019	BUY	$22.67 - $35.0 $2.35 Million - $3.63 Million	103,590 Added 6.12%	1,795,468 $49.9 Million
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $5,412 - $6,974	-201 Reduced 0.01%	1,691,878 $56.2 Million
Q4 2018 Feb 12, 2019	BUY	$27.23 - $45.56 $927,617 - $1.55 Million	34,066 Added 2.05%	1,692,079 $49.2 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $5.41 Million - $7.24 Million	-143,869 Reduced 7.98%	1,658,013 $76.3 Million
Q2 2018 Sep 18, 2018	SELL	$27.75 - $40.17 $126,179 - $182,652	-4,547 Reduced 0.25%	1,801,882 $67.3 Million
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $1.46 Million - $2.11 Million	52,541 Added 3.0%	1,806,429 $67.5 Million
Q1 2018 May 09, 2018	BUY	$28.83 - $41.01 $2.97 Million - $4.22 Million	102,920 Added 6.23%	1,753,888 $51.8 Million
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $3.36 Million - $4.38 Million	117,934 Added 7.69%	1,650,968 $56.7 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $36.8 Million - $55.5 Million	1,533,034	1,533,034 $55.5 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Myriad Genetics Inc Transaction History